Correlation Between NLS Pharmaceutics and Eyenovia
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Eyenovia, you can compare the effects of market volatilities on NLS Pharmaceutics and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Eyenovia.
Diversification Opportunities for NLS Pharmaceutics and Eyenovia
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NLS and Eyenovia is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Eyenovia go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Eyenovia
Given the investment horizon of 90 days NLS Pharmaceutics AG is expected to generate 0.36 times more return on investment than Eyenovia. However, NLS Pharmaceutics AG is 2.81 times less risky than Eyenovia. It trades about -0.08 of its potential returns per unit of risk. Eyenovia is currently generating about -0.25 per unit of risk. If you would invest 386.00 in NLS Pharmaceutics AG on August 31, 2024 and sell it today you would lose (59.00) from holding NLS Pharmaceutics AG or give up 15.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Eyenovia
Performance |
| Timeline |
| NLS Pharmaceutics |
| Eyenovia |
NLS Pharmaceutics and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Eyenovia
The main advantage of trading using opposite NLS Pharmaceutics and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |